Home/All Molecules/Mebeverine

Mebeverine Range

Comprehensive Mebeverine portfolio for Franchise & Manufacturing.

Category
mebeverine
Total Formulations
4
Available Forms
Capsule, Sachet, Tablets

Expand Your Business with Our Multiple Divisions


Browse Mebeverine portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Mebeverine batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Mebeverine PCD Pharma Franchise Company

Mebeverine PCD Pharma Franchise Company

Cafoli Lifecare is a trusted Mebeverine PCD pharma franchise company in India, offering 4 Mebeverine formulations manufactured at WHO-GMP certified facilities. The range is supplied in tablet, capsule and sachet form, including sustained-release presentations suited to long-term gastro therapy.

What is Mebeverine?

Mebeverine is a musculotropic antispasmodic that acts directly on the smooth muscle of the gastrointestinal tract. Unlike anticholinergic antispasmodics, it relieves intestinal spasm without producing atropine-like side effects such as dry mouth and blurred vision. It is used chiefly for the symptomatic relief of irritable bowel syndrome and related abdominal cramping. Compound details are available on PubChem.

Therapeutic Applications

Mebeverine is indicated for the symptomatic management of irritable bowel syndrome, relief of intestinal spasm and abdominal cramping, functional gastrointestinal disorders with pain and bloating, and spastic conditions of the colon. It is prescribed by gastroenterologists, general physicians, general surgeons and consulting physicians managing functional gut disorders.

Why Mebeverine is a High-Potential Molecule for Distributors

The commercial strength of Mebeverine lies in its side-effect profile. Because it works directly on gut smooth muscle rather than through anticholinergic blockade, it avoids the dry mouth, blurred vision and urinary hesitancy that cause patients to abandon older antispasmodics — so prescribers keep patients on it. Irritable bowel syndrome is a chronic, relapsing condition, which means therapy is measured in months and years, not days. That combination of high tolerability and chronic indication produces one of the most reliable repeat-prescription cycles in the gastro segment, and sustained-release forms further extend the course length per pack.

Why Choose Cafoli Lifecare

We offer exclusive monopoly rights across your chosen territory, WHO-GMP certified and DCGI-approved manufacturing, dependable stock availability, competitive margins, and complete promotional inputs including visual aids, samples, MR bags, catch covers and reminder cards. Cafoli Lifecare supports 1000+ franchise partners across India.

References

  1. PubChem — Mebeverine Compound Summary, National Library of Medicine
  2. PubMed — Clinical literature on Mebeverine in IBS

Aceclofenac in Modern Clinical Practice

Our formulations of Mebeverine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Mebeverine in PCD Franchise

Start Your Mebeverine Franchise with Cafoli Lifecare

Add a chronic-therapy gastro line with strong repeat value and monopoly rights in your district. Call +91 95184 47302 or email info@cafoli.in for the latest Mebeverine price list, packing details and territory availability.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 4 Mebeverine formulations in tablet, capsule and sachet form, including sustained-release presentations used in irritable bowel syndrome. Call 9518447302 for the current list with packing and pricing details.

Yes. Monopoly rights are granted on a district or territory basis, so no other franchise partner is appointed in your allotted area for the Mebeverine portfolio. This is confirmed in writing in your agreement.

Mebeverine is prescribed mainly by gastroenterologists, and also by general physicians, general surgeons and consulting physicians treating irritable bowel syndrome and functional gastrointestinal disorders.

Mebeverine acts directly on gut smooth muscle rather than through anticholinergic blockade, so it avoids the dry mouth and blurred vision that make patients abandon older antispasmodics. Since irritable bowel syndrome is chronic and relapsing, therapy runs for months or years, producing highly predictable repeat orders.

A valid Drug License and a GST registration number are required. Share these along with your preferred territory and our team will confirm availability and send the price list and agreement.